Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
09/20/1995 | EP0672186A1 Improved strand displacement assay and complex useful therefor |
09/20/1995 | EP0672183A1 Methods and pharmaceutical kits useful for detecting microorganisms associated with vaginal infections |
09/20/1995 | EP0672181A1 Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor |
09/20/1995 | EP0672180A1 Oligonucleotide modulation of protein kinase c |
09/20/1995 | EP0672178A1 Oligonucleotide modulation of cell growth |
09/20/1995 | EP0672176A1 A method for amplifying and detecting a target nucleic acid sequence of hiv-1 |
09/20/1995 | EP0672172A1 Detecting digeorge syndrome mutations |
09/20/1995 | EP0672171A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers which comprise purine base analogs |
09/20/1995 | EP0672160A1 Activating expression of an amplifying endogenous gene by homologous recombination |
09/20/1995 | EP0672153A1 Vector to deliver and express foreign gene |
09/20/1995 | EP0672151A1 Inhibitors of ced-3 and related proteins |
09/20/1995 | EP0672147A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
09/20/1995 | EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides |
09/20/1995 | EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
09/20/1995 | EP0672140A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
09/20/1995 | EP0672139A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
09/20/1995 | EP0672133A1 TNF-$g(a) RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
09/20/1995 | EP0672132A1 Receptor internalization signals |
09/20/1995 | EP0672122A1 Oligonucleotides with rna cleavage activity |
09/20/1995 | EP0672067A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
09/20/1995 | EP0672064A1 Op-3-induced morphogenesis |
09/20/1995 | EP0672060A1 Antigen associated with type i diabetes mellitus |
09/20/1995 | EP0672048A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
09/20/1995 | EP0652972A4 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure. |
09/20/1995 | EP0643778A4 Encoded combinatorial chemical libraries. |
09/20/1995 | EP0525095B1 HYBRIDIZATION PROBES DERIVED FROM THE SPACER REGION BETWEEN THE 16S AND 23S rRNA GENES FOR THE DETECTION OF NON-VIRAL MICROORGANISMS |
09/19/1995 | US5451663 Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
09/19/1995 | US5451576 Tumor imaging and treatment by water soluble texaphyrin metal complexes |
09/19/1995 | US5451512 Amplifying a region of the hla-a locus by polymerase chain reaction using oligonucleotide primers |
09/19/1995 | US5451505 Detection and identification |
09/19/1995 | US5451503 Method for use of branched nucleic acid probes |
09/19/1995 | US5451463 Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides |
09/14/1995 | WO1995024505A1 Modifying nucleotide analogues |
09/14/1995 | WO1995024490A1 Cell surface protein and effector cell bonding reagent |
09/14/1995 | WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | WO1995024486A1 ANTIMICROBIAL PROTEINS FROM ARALIA AND $i(IMPATIENS) |
09/14/1995 | WO1995024485A2 Coordinate in vivo gene expression |
09/14/1995 | WO1995024479A1 Novel thiol protease inhibitor |
09/14/1995 | WO1995024473A1 Vascular endothelial growth factor 2 |
09/14/1995 | WO1995024466A1 Transforming growth factor alpha h1 |
09/14/1995 | WO1995024427A1 Hybrid human/animal factor viii |
09/14/1995 | WO1995024414A1 Fibroblast growth factor-10 |
09/14/1995 | WO1995024413A1 Compositions and methods for use in the synthesis of oligonucleotides |
09/14/1995 | WO1995024411A1 Corpuscles of stannius protein, stanniocalcin |
09/14/1995 | WO1995024202A1 Ribozyme therapy for restenosis |
09/14/1995 | WO1995024198A1 DIROFILARIA IMMITIS Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
09/14/1995 | WO1995024185A1 Novel pyrimidine nucleosides |
09/14/1995 | WO1995024182A1 Human osteoclast-derived cathepsin |
09/14/1995 | WO1995003406A3 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
09/14/1995 | CA2443236A1 Human osteoclast-derived cathepsin |
09/14/1995 | CA2414016A1 Vascular endothelial growth factor 2 |
09/14/1995 | CA2185327A1 Hybrid human/animal factor viii |
09/14/1995 | CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | CA2184989A1 Ribozyme therapy for restenosis |
09/14/1995 | CA2184905A1 Corpuscles of stannius protein, stanniocalcin |
09/14/1995 | CA2184583A1 Transforming growth factor alpha h1 |
09/14/1995 | CA2183963A1 Dirofilaria immitis gp29 proteins, nucleic acid molecules and uses thereof |
09/14/1995 | CA2183961A1 Fibroblast growth factor-10 |
09/14/1995 | CA2180353A1 Antimicrobial proteins from aralia and impatiens |
09/13/1995 | EP0670905A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
09/13/1995 | EP0670904A1 Vector for the expression of therapy-relevant genes |
09/13/1995 | EP0670899A1 Heat shock proteins and the treatment of tumours |
09/13/1995 | EP0670898A1 Interleukin-3 (il-3) mutant polypeptides |
09/13/1995 | EP0670897A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE |
09/13/1995 | EP0670847A1 Subtilin variant of enhanced stability and activity |
09/13/1995 | EP0670733A1 Compositions containing growth factors and antiplastic agents |
09/13/1995 | EP0661979A4 Cross-linking oligonucleotides for enzyme-mediated triple strand formation. |
09/13/1995 | EP0265519B1 Electrochemiluminescent assays |
09/12/1995 | US5449769 Method and reagent for sulfurization of organophosphorous compounds |
09/12/1995 | US5449767 Modified polynucleotides and methods of preparing same |
09/12/1995 | US5449755 Human cyclin E |
09/12/1995 | US5449608 Detection |
09/12/1995 | US5449602 Polynucleotides |
09/08/1995 | WO1995023865A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
09/08/1995 | WO1995023860A2 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR |
09/08/1995 | WO1995023856A1 Chimeric complement inhibitor proteins |
09/08/1995 | WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
09/08/1995 | WO1995023512A1 Terminal complement inhibitor fusion genes and proteins |
09/08/1995 | WO1995021927A3 Targeting gene therapy |
09/08/1995 | WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication |
09/08/1995 | CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
09/08/1995 | CA2184356A1 Terminal complement inhibitor fusion genes and proteins |
09/08/1995 | CA2184355A1 Chimeric complement inhibitor proteins |
09/08/1995 | CA2184058A1 Kunitz domain inhibitor proteins derived from alzheimer's amyloid .beta.-protein precursor inhibitor |
09/08/1995 | CA2181787A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
09/06/1995 | EP0670373A1 Probe for diagnosing infectious diseases |
09/06/1995 | EP0670332A2 Protein complexes having factor VIII:C activity and production thereof |
09/06/1995 | EP0670329A2 Enzyme-nucleic acid hydrazone and hydrazine conjugate compositions and methods |
09/06/1995 | EP0670164A1 Homeopathic solutions containing a nucleic acid |
09/06/1995 | EP0669990A1 Identification of neoplasms by detection of genetic insertions and deletions |
09/06/1995 | EP0669987A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
09/06/1995 | EP0669983A1 Allergenic proteins and peptides from japanese cedar pollen |
09/06/1995 | EP0669979A1 C-c ckr-1, c-c chemokine receptor |
09/06/1995 | EP0669978A1 Flk-1 is a receptor for vascular endothelial growth factor |
09/06/1995 | EP0669977A1 Transformed endothelial cells |
09/06/1995 | EP0669976A1 Transcription factor dp-1 |
09/06/1995 | EP0669929A1 Novel cytokine designated elk ligand |
09/06/1995 | EP0669928A1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
09/06/1995 | EP0669927A1 Sequence-specific binding polymers for duplex nucleic acids |
09/06/1995 | EP0669926A1 Permeability enhancers for ionic therapeutic polymers |